GeneCraft Labs, together with QIAGEN and Airlangga University held a Halal Identification Workshop with the Real Time PCR Method in Surabaya. The workshop which took place on September 25, 2018 at Airlangga University’s Biosafety Level II Infectious Tropical Disease Laboratory open for the public, industry and research community in East Java. This seminar and workshop was aim to elaborate in detail about Halal Test workflow and Data Evaluation using Real Time PCR or qPCR. In addition to research and practitioner from Airlangga University, many other participants from different institution such as Provincial Agriculture Laboratory, Center for Agricultural Quarantine Surabaya, UPN Veteran East Java and also Maliki UIN Malang.
Analysis of laboratory to detect the presence or absence of pork contaminants is one of the supporting processes for halal certification. Halal testing in Indonesia getting much more important recently due to the facts of large Moslem population in Indonesia. Halal Test with PCR is a very sensitive and accurate method because the ability to detect the smallest element in an organism, DNA, so that false negative can be avioided. The real time PCR method is not only able to detect swine contaminants against the main products but also swine contaminants in derivative products such as gelatin, capsules, cosmetics and many others.
Rotorgene-Q from QIAGEN was being used in order to perform the workshop. This real time PCR has a high speed performance with only as short as 70 minutes per run. Rotorgene-Q uniformity that is produced during the workshop is excellent, with a level of uniformity reaching 0.01 degrees Celsius. This is very useful and handy to avoid false positive results.
Drh. Lita Rakhma, M.Vet as the representative of the Airlangga University Halal Center in her speech said, “Hopefully this workshop can help the research and practioner community to improve the testing solution and research in the Halal sector.”
QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries. QIAGEN’s shares are listed at the NYSEand at the Frankfurt Stock Exchange in the Prime Standard. The main operative headquarters are located in Hilden, Germany